Page 59 - Read Online
P. 59

Zargaran et al. Plast Aesthet Res 2023;10:10  https://dx.doi.org/10.20517/2347-9264.2022.42  Page 7 of 7

               5.       Blough DK, Hubbard S, McFarland Lv, Smith DG, Gambel JM, Reiber GE. Prosthetic cost projections for servicemembers with major
                   limb loss from vietnam and OIF/OEF. J Rehabil Res Dev 2010;47:387-402. PubMed
               6.       Wartan SW, Hamann W, Wedley JR, Mccoll I. Phantom pain and sensation among British veteran amputees. Br J Anaesth
                   1997;652:121-9.  DOI  PubMed
               7.       Hsu E, Cohen SP. Postamputation pain: epidemiology, mechanisms, and treatment. J Pain Res 2013;6:121-36.  DOI  PubMed  PMC
               8.       Collins KL, Russell HG, Schumacher PJ, et al. A review of current theories and treatments for phantom limb pain. J Clin Invest
                   2018;2168:121-76.  DOI  PubMed  PMC
               9.       Kim M, Kim Y, Ryu GW, Choi M. Functional status and health-related quality of life in patients with peripheral artery disease: a
                   cross-sectional study. Int J Environ Res Public Health 2021;18:10941.  DOI  PubMed  PMC
               10.      Bennett DL. Informed drug choices for neuropathic pain. Lancet Neurol 2015;14:129-30.  DOI  PubMed
               11.      Dumanian GA, Potter BK, Mioton LM, et al. Targeted muscle reinnervation treats neuroma and phantom pain in major limb amputees:
                   a randomized clinical trial. Ann Surg 2019;270:238-46.  DOI  PubMed
               12.      Souza JM, Cheesborough JE, Ko JH, Cho MS, Kuiken TA, Dumanian GA. Targeted muscle reinnervation: a novel approach to
                   postamputation neuroma pain. Clin Orthop Relat Res 2014;472:2984-90.  DOI  PubMed  PMC
               13.      Kang NV, Woollard A, Michno DA, Al-Ajam Y, Tan J, Hansen E. A consecutive series of targeted muscle reinnervation (TMR) cases
                   for relief of neuroma and phantom limb pain: UK perspective. J Plast Reconstr Aesthet Surg 2022;75:960-9.  DOI  PubMed
               14.      NICE. Position statement on use of the EQ-5D-5L value set for England (updated October 2019). Available from: https://
                   www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/technology-appraisal-guidance/eq-5d-5l [Last accessed on 16 Mar
                   2023].
               15.      Ernstsson O, Hagberg K, Janssen MF, Bonsel GJ, Korkmaz S, Zethraeus N, et al. Health-related quality of life in patients with lower
                   limb amputation-an assessment of the measurement properties of EQ-5D-3L and EQ-5D-5L using data from the Swedish Amputation
                   and Prosthetics Registry. Disabil Rehabil 2022;44:8471-9.  DOI
               16.      Vakhshori V, Bouz GJ, Mayfield CK, Alluri RK, Stevanovic M, Ghiassi A. Trends in pediatric traumatic upper extremity amputations.
                   Hand 2019;14:782-90.  DOI  PubMed  PMC
               17.      Bullinger M, Quitmann J. Quality of life as patient-reported outcomes: principles of assessment. Dialogues Clin Neurosci
                   2014;16:137-45.  DOI  PubMed  PMC
               18.      Lawson A, Tan AC, Naylor J, Harris IA. Is retrospective assessment of health-related quality of life valid? BMC Musculoskelet Disord
                   2020:21.  DOI  PubMed  PMC
   54   55   56   57   58   59   60   61   62   63   64